HEMATOLOGY ONCOLOGY. CLINICAL QUESTIONS

HEMATOLOGY ONCOLOGY. CLINICAL QUESTIONS

Editorial:
MCGRAW HILL
Año de edición:
Materia
Oncología
ISBN:
978-1-260-02662-7
Páginas:
608
N. de edición:
1
Idioma:
Inglés
Disponibilidad:
Disponible en 2 semanas

Descuento:

-5%

Antes:

86,70 €

Despues:

82,37 €

1. CHEMOTHERAPY AGENTS "WILL INCLUDE A SUMMARY OF EACH TYPE BEFORE CLINICAL QUESTIONS
a. Cytotoxic
b. Targeted Agents
c. Hormonal Agents
d. Immunotherapy
2. RADIATION THERAPY
3. MOST COMMON HEME QUESTIONS
a. Anemia
b. Thrombocytopenia
c. Thrombosis
d. Transfusion reactions
4. SCREENING
a. Breast cancer
b. Cervical
c. Colon Cancer
d. Prostate
e. Lung Cancer
5. BREAST CANCER
a. Non-invasive
b. Invasive
c. Inflammatory breast cancer
d. Phyllodes
e. Paget's
6. HEAD AND NECK
7. THYROID CARCINOMAS
8. GI CANCER
a. Esophagus
b. Gastric/GEJ
c. Colon
d. Rectal
e. Anus
f. Pancreas
g. Cholangiocarcinoma
h. Hepatocellular Carcinoma
i. Neuroendocrine tumors
9. GU CANCER
a. Bladder
b. Kidney
c. Prostate
d. Testicular
10. GYNECOLOGICAL MALIGNANCIES
a. Cervical
b. Endometrial
c. Ovarian
d. Uterine
11. MELANOMAS
12. THORACIC
a. Small cell lung cancer
b. Non-small cell lung cancer
13. SARCOMAS
14. OCCULT PRIMARY
15. BASICS OF PATHOLOGY AND HEMATOLOGY
a. Bone Marrow, Flow Cytometry, Cytogenetics, Molecular testing.
b. Solid tumor pathology basics
16. BASICS OF BONE MARROW TRANSPLANTATION
a. Types (Allo, Auto)
b. Indications
17. LYMPHOMAS
a. Hodgkin's Lymphoma
i. Classical HL
ii. Nodular lymphocyte-predominant HL
b. Non-Hodgkin's Lymphoma
i. B-cell NHL
a) Diffuse large B-cell Lymphoma (DLBCL)
b) Follicular Lymphoma
c) Mantle Cell Lymphoma (MCL)
d) Small Lymphocytic Lymphoma (SLL)
e) Primary CNS Lymphoma
f) Primary Mediastinal Lymphoma (PML)
g) Burkitt Lymphoma (BL)
h) Primary Effusion Lymphoma
i) Double-hit Lymphoma
j) Primary Effusion Lymphoma (PEL)
ii. T-Cell NHL
a) Peripheral T-cell Lymphoma (PTCL)
b) Primary Cutaneous T-cell Lymphoma
c) Anaplastic Large Cell Lymphoma (ALCL)
d) Post-Transplant Lymphoproliferative
18. LEUKEMIAS
a) Acute Leukemias
i. Acute Myeloid Leukemia (AML)
ii. APL
i. Acute Lymphoblastic Leukemia (ALL)
b) Chronic Leukemias:
i. Chronic Myeloid Leukemia (CML)
ii. Chronic Lymphocytic Leukemia (CLL)
iii. Hairy Cell Leukemia
19. PLASMA CELL DISORDERS:
a. Monoclonal Gammopathy of Undetermined Significance (MGUS)
b. Multiple Myeloma (MM)
c. Lymphoplasmacyctic Lymphoma (including Waldenstrom's Macroglobulinemia)
d. Solitary Plasmacytoma
e. AL Amyloidosis
f. POEMS Syndrome
20. MYELOPROLIFERATIVE NEOPLASMS
a. Polycythemia Vera (PV)
b. Essential Thrombocythemia (ET)
c. Primary Myelofibrosis (PMF)
d. Systemic Mastocytosis (SM)
21. MYELODYSPLASTIC SYNDROMES
22. GUIDELINES FOR SUPPORTIVE CARE
a. Management of Side Effects of Chemotherapy
i. Myelosuppression
ii. Nausea
iii. Vomiting
iv. Diarrhea
v. Mucositis
vi. Anorexia, weight loss
b. Management of Cancer-related pain
c. Management of Cachexia
23. ONCOLOGIC EMERGENCIES
a. Neutropenic Fever
b. Spinal Cord Compression
c. Tumor Lysis Syndrome
d. Superior vena cava syndrome
e. Hypercalcemia of malignancy
f. Hyperleukocytosis and leukostasis
24. GENETIC AND FAMILIAL ASSESSMENT FOR FAMILIAL CANCER SYNDROMES
25. END OF LIFE

A unique point-of-care guide to clinical hematology-oncology
Hematology-Oncology Clinical Questions answers the questions most frequently asked by medical students or residents on rotations. The answers provided are concise, specific, evidence-based, and supported by recent references and clinical practice guidelines. Readers will find Hematology-Oncology Clinical Questions to be single-best resource for quickly translating the most current knowledge into practical, diagnostic real-time solutions.

• Coverage includes both solid tumor and hematology malignancies, cancer screening and genetic and familial cancer syndrome, supportive care and end of life, chemotherapy agents (including immunotherapy)
• The content arrangement is designed to simulate the consultation process: data collection, synthesis of data, solution